Quercitrin inhibits platelet activation in arterial thrombosis

Tae Woo Oh, Hyun Ju Do, Jae Han Jeon, Kyungho Kim

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Background: The ingestion of flavonoids has been reported to be associated with reduced cardiovascular disease risk. Quercitrin is a common flavonoid in nature, and it exhibits antioxidant properties. Although the process of thrombogenesis is intimately related to cardiovascular disease risk, it is unclear whether quercitrin plays a role in thrombogenesis. Purpose: The aim of this study was to examine the antiplatelet effect of quercitrin in platelet activation. Methods: Platelet aggregation, granule secretion, calcium mobilization, and integrin activation were used to assess the antiplatelet activity of quercitrin. Antithrombotic effect was determined in mouse using ferric chloride (FeCl3)-induced arterial thrombus formation in vivo and thrombus formation on collagen-coated surfaces under arteriolar shear in vitro. Transection tail bleeding time was used to evaluate whether quercitrin inhibited primary hemostasis. Results: Quercitrin significantly impaired collagen-related peptide-induced platelet aggregation, granule secretion, reactive oxygen species generation, and intracellular calcium mobilization. Outside-in signaling of αIIbβ3 integrin was significantly inhibited by quercitrin in a concentration-dependent manner. The inhibitory effect of quercitrin resulted from inhibition of the glycoprotein VI-mediated platelet signal transduction during cell activation. Further, the antioxidant effect is derived from decreased phosphorylation of components of the TNF receptor-associated factor 4/p47phox/Hic5 axis signalosome. Oral administration of quercitrin efficiently blocked FeCl3-induced arterial thrombus formation in vivo and thrombus formation on collagen-coated surfaces under arteriolar shear in vitro, without prolonging bleeding time. Studies using a mouse model of ischemia/reperfusion-induced stroke indicated that treatment with quercitrin reduced the infarct volume in stroke. Conclusions: Our results demonstrated that quercitrin could be an effective therapeutic agent for the treatment of thrombotic diseases.

Original languageEnglish
Article number153363
JournalPhytomedicine
Volume80
DOIs
StatePublished - Jan 2021

Keywords

  • Flavonoids
  • Glycoprotein VI
  • Platelet
  • Quercitrin
  • Thrombosis

Fingerprint

Dive into the research topics of 'Quercitrin inhibits platelet activation in arterial thrombosis'. Together they form a unique fingerprint.

Cite this